Clinical trial
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
NCT07217678 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
- Lead sponsor
- University of Miami
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 9, 2026
- Completion date
- January 31, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, glaucoma suspect, ocular hypertension, open-angle glaucoma